John Mendelsohn - Director, Merrimack Pharmaceuticals Inc

As of September 15, 2017


John Mendelsohn Net Worth

  • Net worth is estimated to be at least $20.18K
  • Owns at least 5,000 units of Merrimack Pharmaceuticals Inc stock

John Mendelsohn Trading

  • Largest purchase of shares was 5,000 units , worth over $33.14K on December 18, 2012
  • In total has made about 7 transactions over 5 years
  • Usually trades in June and May, with the busiest year in 2012
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Merrimack Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Gary L. Crocker 2019 $76,000 $ $19,258 $ $ $95,258
Richard Peters 2019 $383,676 $294,891 $ $ $935,369 $1,613,936
Jean M. Franchi 2019 $214,087 $77,544 $ $ $524,461 $816,092
Jeffrey A. Munsie 2019 $209,658 $72,015 $ $ $478,659 $760,332
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1274792/000119312521126831/d97305ddef14a.htm

Merrimack Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 3,100 units bought on January 27, 2022 by Gary L Crocker worth over $14.12K
  • In the last 10 years, insiders at Merrimack Pharmaceuticals Inc sold an estimated value of $15.57M and bought an estimated value of $19.95M
  • The most active traders are Gary L Crocker, See Remarks,  Michael Porter, Director,  and Edward Stewart, Head Commercial
  • Insider trading is most common in June and April, with the busiest year in 2015

MERRIMACK PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1